Bioink-based 3D bioprinting: Paving the path for regenerative medicine

Area of Science:

• Biotechnology
• Regenerative Medicine
• Materials Science

Background:

• Three-dimensional (3D) bioprinting is a transformative bio-fabrication technology.
• Developing bioinks with optimal cellular compatibility, mechanical strength, printability, and biodegradability is a critical challenge.
• Advancements in 4D bioprinting, supramolecular hydrogels, and polymers are driving bioink innovation.

Purpose of the Study:

• To review the current state and future directions of 3D bioprinting.
• To highlight key challenges and opportunities in bioink development and application.
• To discuss the potential of 3D bioprinting in personalized regenerative medicine and disease treatment.

Main Methods:

• Exploration of various bioprinting techniques including extrusion, inkjet, and stereolithography.
• Integration of induced pluripotent stem cells (iPSCs), organ-on-chip technologies, and microfluidics.
• Application of artificial intelligence (AI) and automation for quality control.

Main Results:

• 3D bioprinting enables the creation of detailed tissues for drug therapy and disease diagnosis.
• iPSCs, organ-on-chip, and microfluidics facilitate sensitive tissue production.
• AI and automation offer valuable solutions for quality control in bioprinting processes.

Conclusions:

• Overcoming limitations such as regulations, bioink consistency, and long-term security is crucial for clinical translation.
• Development of scalable, cost-effective, and GMP-compliant bioprinting platforms is essential.
• Interdisciplinary collaboration is key to realizing the potential of 3D bioprinting for personalized regenerative medicine and treating diseases like cancer and heart disease.